OJI  Vol.4 No.3 , September 2014
Temporal Transcriptional Regulation of IL-10-Induced Anti-Inflammatory Genes in LPS-Triggered Macrophages
Abstract: Interleukin-10 (IL-10) mediates an anti-inflammatory response that is executed through the expression of IL-10-induced genes. Certain IL-10-induced genes, exemplified by TNIP3, are induced by IL-10 only in conjunction with a pro-inflammatory signal. We sought to characterize the mechanism whereby IL-10 and Toll-like receptor signals synergized to induce expression of genes like TNIP3 inmacrophages. Stimulation with IL-10 and lipopolysaccharide (LPS) synergistically induced an increase in the transcription rate of TNIP3, while having no effect on its mRNA stability. This transcriptional mechanism proved to be generalizable to 14 other genes that also were synergistically induced by IL-10 and LPS in monocytes/macrophages. Although all of the genes had this synergistic transcriptional regulation in common, they could be divided into three subsets based on their differential requirements for de novo protein synthesis and kinetics of expression: namely, primary response genes, early secondary response genes, and late secondary response genes. This coordinated and temporal pattern of transcriptional regulation in response to IL-10 and LPS was conserved in both human and mouse monocytes/macrophages, and it was associated with differential dependencies on PI3K and JNK signaling pathways. These results underscore the complex nature of the IL-10-induced transcriptional response that occurs specifically in LPS-triggered macrophages.
Cite this paper: Dillow, A. , Cardwell, L. , Smith, T. , Groppe, B. , Peterson, B. , Sickman, M. and Weaver, B. (2014) Temporal Transcriptional Regulation of IL-10-Induced Anti-Inflammatory Genes in LPS-Triggered Macrophages. Open Journal of Immunology, 4, 96-116. doi: 10.4236/oji.2014.43013.

[1]   Martinez, F.O., Sica, A., Mantovani, A. and Locati, M. (2008) Macrophage Activation and Polarization. Frontiers in Bioscience, 13, 453-461.

[2]   Martinez, F.O., Helming, L. and Gordon, S. (2009) Alternative Activation of Macrophages: An Immunologic Functional Perspective. Annual Review of Immunology, 27, 451-483.

[3]   Medzhitov, R. (2008) Origin and Physiological Roles of Inflammation. Nature, 454, 428-435.

[4]   Serbina, N.V., Jia, T., Hohl, T.M. and Pamer, E.G. (2008) Monocyte-Mediated Defense against Microbial Pathogens. Annual Review of Immunology, 26, 421-452.

[5]   Broz, P. and Monack, D.M. (2013) Newly Described Pattern Recognition Receptors Team up against Intracellular Pathogens. Nature Reviews Immunology, 13, 551-565.

[6]   Onoguchi, K., Yoneyama, M. and Fujita, T. (2011) Retinoic Acid-Inducible Gene-I-Like Receptors. Journal of Interferon & Cytokine Research, 31, 27-31.

[7]   Palm, N.W. and Medzhitov, R. (2009) Pattern Recognition Receptors and Control of Adaptive Immunity. Immunological Reviews, 227, 221-233.

[8]   Takeuchi, O. and Akira, S. (2010) Pattern Recognition Receptors and Inflammation. Cell, 140, 805-820.

[9]   Arpaia, N. and Barton, G.M. (2011) Toll-Like Receptors: Key Players in Antiviral Immunity. Current Opinion in Virology, 1, 447-454.

[10]   Barton, G.M. and Medzhitov, R. (2002) Toll-Like Receptors and Their Ligands. Current Topics in Microbiology and Immunology, 270, 81-92.

[11]   Blasius, A.L. and Beutler, B. (2010) Intracellular Toll-Like Receptors. Immunity, 32, 305-315.

[12]   Kawai, T. and Akira, S. (2010) The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors. Nature Immunology, 11, 373-384.

[13]   O’Neill, L.A. and Bowie, A.G. (2007) The Family of Five: TIR-Domain-Containing Adaptors in Toll-Like Receptor Signalling. Nature Reviews Immunology, 7, 353-364.

[14]   Takeda, K. and Akira, S. (2005) Toll-Like Receptors in Innate Immunity. International Immunology, 17, 1-14.

[15]   Yamamoto, M. and Akira, S. (2005) TIR Domain-Containing Adaptors Regulate TLR Signaling Pathways. Advances in Experimental Medicine and Biology, 560, 1-9.

[16]   Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O’Garra, A. (2001) Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology, 19, 683-765.

[17]   Sabat, R., Grutz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K. and Geginat, J. (2010) Biology of Interleukin-10. Cytokine & Growth Factor Reviews, 21, 331-344.

[18]   Saraiva, M. and O’Garra, A. (2010) The Regulation of IL-10 Production by Immune Cells. Nature Reviews Immunology, 10, 170-181.

[19]   Murray, P.J. (2006) Understanding and Exploiting the Endogenous Interleukin-10/STAT3-Mediated Anti-Inflamma- tory Response. Current Opinion in Pharmacology, 6, 379-386.

[20]   Grutz, G. (2005) New Insights into the Molecular Mechanism of Interleukin-10-Mediated Immunosuppression. Journal of Leukocyte Biology, 77, 3-15.

[21]   Williams, L.M., Ricchetti, G., Sarma, U., Smallie, T. and Foxwell, B.M. (2004) Interleukin-10 Suppression of Myeloid Cell Activation—A Continuing Puzzle. Immunology, 113, 281-292.

[22]   Hutchins, A.P., Diez, D. and Miranda-Saavedra, D. (2013) The IL-10/STAT3-Mediated Anti-Inflammatory Response: Recent Developments and Future Challenges. Briefings in Functional Genomics, 12, 489-498.

[23]   Smallie, T., Ricchetti, G., Horwood, N.J., Feldmann, M., Clark, A.R. and Williams, L.M. (2010) IL-10 Inhibits Transcription Elongation of the Human TNF Gene in Primary Macrophages. Journal of Experimental Medicine, 207, 2081- 2088.

[24]   Murray, P.J. (2005) The Primary Mechanism of the IL-10-Regulated Antiinflammatory Response Is to Selectively Inhibit Transcription. Proceedings of the National Academy of Sciences of the United States of America, 102, 8686-8691.

[25]   Biswas, R., Datta, S., Gupta, J.D., Novotny, M., Tebo, J. and Hamilton, T.A. (2003) Regulation of Chemokine mRNA Stability by Lipopolysaccharide and IL-10. Journal of Immunology, 170, 6202-6208.

[26]   Kontoyiannis, D., Kotlyarov, A., Carballo, E., Alexopoulou, L., Blackshear, P.J., Gaestel, M., Davis, R., Flavell, R. and Kollias, G. (2001) Interleukin-10 Targets p38 MAPK to Modulate ARE-Dependent TNF mRNA Translation and Limit Intestinal Pathology. EMBO Journal, 20, 3760-3770.

[27]   Kim, H.S., Armstrong, D., Hamilton, T.A. and Tebo, J.M. (1998) IL-10 Suppresses LPS-Induced KC mRNA Expression via a Translation-Dependent Decrease in mRNA Stability. Journal of Leukocyte Biology, 64, 33-39.

[28]   Correa, I., Veny, M., Esteller, M., Pique, J.M., Yague, J., Panes, J. and Salas, A. (2009) Defective IL-10 Production in Severe Phenotypes of Crohn’s Disease. Journal of Leukocyte Biology, 85, 896-903.

[29]   Glocker, E.O., Kotlarz, D., Klein, C., Shah, N. and Grimbacher, B. (2011) IL-10 and IL-10 Receptor Defects in Humans. Annals of the New York Academy of Sciences, 1246, 102-107.

[30]   Parkes, M., Satsangi, J. and Jewell, D. (1998) Contribution of the IL-2 and IL-10 Genes to Inflammatory Bowel Disease (IBD) Susceptibility. Clinical and Experimental Immunology, 113, 28-32.

[31]   Shah, N., Kammermeier, J., Elawad, M. and Glocker, E.O. (2012) Interleukin-10 and Interleukin-10-Receptor Defects in Inflammatory Bowel Disease. Current Allergy & Asthma Reports, 12, 373-379.

[32]   Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W. (1993) Interleukin-10-Deficient Mice Develop Chronic Enterocolitis. Cell, 75, 263-274.

[33]   Spencer, S.D., Di Marco, F., Hooley, J., Pitts-Meek, S., Bauer, M., Ryan, A.M., Sordat, B., Gibbs, V.C. and Aguet, M. (1998) The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor. Journal of Experimental Medicine, 187, 571-578.

[34]   Pils, M.C., Pisano, F., Fasnacht, N., Heinrich, J.M., Groebe, L., Schippers, A., Rozell, B., Jack, R.S. and Muller, W. (2010) Monocytes/Macrophages and/or Neutrophils Are the Target of IL-10 in the LPS Endotoxemia Model. European Journal of Immunology, 40, 443-448.

[35]   Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S. (1999) Enhanced Th1 Activity and Development of Chronic Enterocolitis in Mice Devoid of Stat3 in Macrophages and Neutrophils. Immunity, 10, 39-49.

[36]   Welte, T., Zhang, S.S., Wang, T., Zhang, Z., Hesslein, D.G., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J.E., Bothwell, A.L., Fikrig, E., Koni, P.A., Flavell, R.A. and Fu, X.Y. (2003) STAT3 Deletion during Hematopoiesis Causes Crohn’s Disease-Like Pathogenesis and Lethality: A Critical Role of STAT3 in Innate Immunity. Proceedings of the National Academy of Sciences of the United States of America, 100, 1879-1884.

[37]   Pestka, S., Krause, C.D., Sarkar, D., Walter, M.R., Shi, Y. and Fisher, P.B. (2004) Interleukin-10 and Related Cytokines and Receptors. Annual Review of Immunology, 22, 929-979.

[38]   Donnelly, R.P., Dickensheets, H. and Finbloom, D.S. (1999) The Interleukin-10 Signal Transduction Pathway and Regulation of Gene Expression in Mononuclear Phagocytes. Journal of Interferon & Cytokine Research, 19, 563-573.

[39]   Weber-Nordt, R.M., Riley, J.K., Greenlund, A.C., Moore, K.W., Darnell, J.E. and Schreiber, R.D. (1996) Stat3 Recruitment by Two Distinct Ligand-Induced, Tyrosine-Phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain. Journal of Biological Chemistry, 271, 27954-27961.

[40]   Jung, M., Sabat, R., Kratzschmar, J., Seidel, H., Wolk, K., Schonbein, C., Schutt, S., Friedrich, M., Docke, W.D., Asadullah, K., Volk, H.D. and Grutz, G. (2004) Expression Profiling of IL-10-Regulated Genes in Human Monocytes and Peripheral Blood Mononuclear Cells from Psoriatic Patients during IL-10 Therapy. European Journal of Immunology, 34, 481-493.

[41]   Lang, R., Patel, D., Morris, J.J., Rutschman, R.L. and Murray, P.J. (2002) Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10. Journal of Immunology, 169, 2253-2263.

[42]   Perrier, P., Martinez, F.O., Locati, M., Bianchi, G., Nebuloni, M., Vago, G., Bazzoni, F., Sozzani, S., Allavena, P. and Mantovani, A. (2004) Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13. Journal of Immunology, 172, 7031-7042.

[43]   Weaver, B.K., Bohn, E., Judd, B.A., Gil, M.P. and Schreiber, R.D. (2007) ABIN-3: A Molecular Basis for Species Divergence in Interleukin-10-Induced Anti-Inflammatory Actions. Molecular and Cellular Biology, 27, 4603-4616.

[44]   Williams, L., Jarai, G., Smith, A. and Finan, P. (2002) IL-10 Expression Profiling in Human Monocytes. Journal of Leukocyte Biology, 72, 800-809.

[45]   Antoniv, T.T., Park-Min, K.H. and Ivashkiv, L.B. (2005) Kinetics of IL-10-Induced Gene Expression in Human Macrophages. Immunobiology, 210, 87-95.

[46]   El Kasmi, K.C., Smith, A.M., Williams, L., Neale, G., Panopoulos, A.D., Watowich, S.S., Hacker, H., Foxwell, B.M. and Murray, P.J. (2007) Cutting Edge: A Transcriptional Repressor and Corepressor Induced by the STAT3-Regulated Anti-Inflammatory Signaling Pathway. Journal of Immunology, 179, 7215-7219.

[47]   Hutchins, A.P., Poulain, S. and Miranda-Saavedra, D. (2012) Genome-Wide Analysis of STAT3 Binding in Vivo Predicts Effectors of the anti-Inflammatory Response in Macrophages. Blood, 119, e110-119.

[48]   Smith, A.M., Qualls, J.E., O’Brien, K., Balouzian, L., Johnson, P.F., Schultz-Cherry, S., Smale, S.T. and Murray, P.J. (2011) A Distal Enhancer in Il12b Is the Target of Transcriptional Repression by the STAT3 Pathway and Requires the Basic Leucine Zipper (B-ZIP) Protein NFIL3. Journal of Biological Chemistry, 286, 23582-23590.

[49]   Kuwata, H., Watanabe, Y., Miyoshi, H., Yamamoto, M., Kaisho, T., Takeda, K. and Akira, S. (2003) IL-10-Inducible Bcl-3 Negatively Regulates LPS-Induced TNF-Alpha Production in Macrophages. Blood, 102, 4123-4129.

[50]   Celada, A., Gray, P.W., Rinderknecht, E. and Schreiber, R.D. (1984) Evidence for a Gamma-Interferon Receptor That Regulates Macrophage Tumoricidal Activity. Journal of Experimental Medicine, 160, 55-74.

[51]   Lois, C., Hong, E.J., Pease, S., Brown, E.J. and Baltimore, D. (2002) Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors. Science, 295, 868-872.

[52]   Zhou, L., Nazarian, A.A. and Smale, S.T. (2004) Interleukin-10 Inhibits Interleukin-12 p40 Gene Transcription by Targeting a Late Event in the Activation Pathway. Molecular and Cellular Biology, 24, 2385-2396.

[53]   Antoniv, T.T. and Ivashkiv, L.B. (2011) Interleukin-10-Induced Gene Expression and Suppressive Function Are Selectively Modulated by the PI3K-Akt-GSK3 Pathway. Immunology, 132, 567-577.

[54]   Arthur, J.S. and Ley, S.C. (2013) Mitogen-Activated Protein Kinases in Innate Immunity. Nature Reviews Immunology, 13, 679-692.

[55]   Troutman, T.D., Bazan, J.F. and Pasare, C. (2012) Toll-Like Receptors, Signaling Adapters and Regulation of the Pro- Inflammatory Response by PI3K. Cell Cycle, 11, 3559-3567.

[56]   Medzhitov, R. and Horng, T. (2009) Transcriptional Control of the Inflammatory Response. Nature Reviews Immunology, 9, 692-703.

[57]   Smale, S.T. (2012) Transcriptional Regulation in the Innate Immune System. Current Opinion in Immunology, 24, 51- 57.

[58]   Farlik, M., Reutterer, B., Schindler, C., Greten, F., Vogl, C., Muller, M. and Decker, T. (2010) Nonconventional Initiation Complex Assembly by STAT and NF-kappaB Transcription Factors Regulates Nitric Oxide Synthase Expression. Immunity, 33, 25-34.

[59]   Qiao, Y., Giannopoulou, E.G., Chan, C.H., Park, S.H., Gong, S., Chen, J., Hu, X., Elemento, O. and Ivashkiv, L.B. (2013) Synergistic Activation of Inflammatory Cytokine Genes by Interferon-Gamma-Induced Chromatin Remodeling and Toll-Like Receptor Signaling. Immunity, 39, 454-469.

[60]   Hao, S. and Baltimore, D. (2009) The Stability of mRNA Influences the Temporal Order of the Induction of Genes Encoding Inflammatory Molecules. Nature Immunology, 10, 281-288.

[61]   Hargreaves, D.C., Horng, T. and Medzhitov, R. (2009) Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation. Cell, 138, 129-145.

[62]   Ramirez-Carrozzi, V.R., Braas, D., Bhatt, D.M., Cheng, C.S., Hong, C., Doty, K.R., Black, J.C., Hoffmann, A., Carey, M. and Smale, S.T. (2009) A Unifying Model for the Selective Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling. Cell, 138, 114-128.

[63]   Ramirez-Carrozzi, V.R., Nazarian, A.A., Li, C.C., Gore, S.L., Sridharan, R., Imbalzano, A.N. and Smale, S.T. (2006) Selective and Antagonistic Functions of SWI/SNF and Mi-2beta Nucleosome Remodeling Complexes during an Inflammatory Response. Genes & Development, 20, 282-296.

[64]   Hao, S. and Baltimore, D. (2013) RNA Splicing Regulates the Temporal Order of TNF-Induced Gene Expression. Proceedings of the National Academy of Sciences of the United States of America, 110, 11934-11939.

[65]   Pandya-Jones, A., Bhatt, D.M., Lin, C.H., Tong, A.J., Smale, S.T. and Black, D.L. (2013) Splicing Kinetics and Transcript Release from the Chromatin Compartment Limit the Rate of Lipid A-Induced Gene Expression. RNA, 19, 811- 827.

[66]   Auernhammer, C.J., Bousquet, C. and Melmed, S. (1999) Autoregulation of Pituitary Corticotroph SOCS-3 Expression: Characterization of the Murine SOCS-3 Promoter. Proceedings of the National Academy of Sciences of the United States of America, 96, 6964-6969.

[67]   Ehret, G.B., Reichenbach, P., Schindler, U., Horvath, C.M., Fritz, S., Nabholz, M. and Bucher, P. (2001) DNA Binding Specificity of Different STAT Proteins. Comparison of in Vitro Specificity with Natural Target Sites. Journal of Biological Chemistry, 276, 6675-6688.

[68]   Qin, H., Roberts, K.L., Niyongere, S.A., Cong, Y., Elson, C.O. and Benveniste, E.N. (2007) Molecular Mechanism of Lipopolysaccharide-Induced SOCS-3 Gene Expression in Macrophages and Microglia. Journal of Immunology, 179, 5966-5976.

[69]   Tamassia, N., Castellucci, M., Rossato, M., Gasperini, S., Bosisio, D., Giacomelli, M., Badolato, R., Cassatella, M.A. and Bazzoni, F. (2010) Uncovering an IL-10-Dependent NF-{kappa}B Recruitment to the IL-1ra Promoter That Is Impaired in STAT3 Functionally Defective Patients. FASEB Journal, 24, 1365-1375.

[70]   Verstrepen, L., Adib-Conquy, M., Kreike, M., Carpentier, I., Adrie, C., Cavaillon, J. and Beyeart, R. (2008) Expression of the NF-κB Inhibitor ABIN-3 in Response to TNF and Toll Like Receptor 4 Is Itself Regulated by NF-κB. Journal of Cell and Molecular Medicine, 12, 316-329.

[71]   Kubo, M., Hanada, T. and Yoshimura, A. (2003) Suppressors of Cytokine Signaling and Immunity. Nature Immunology, 4, 1169-1176.

[72]   Alexander, W.S. and Hilton, D.J. (2004) The Role of Suppressors of Cytokine Signaling (SOCS) Proteins in Regulation of the Immune Response. Annual Review of Immunology, 22, 503-529.

[73]   Liu, Y., Shepherd, E.G. and Nelin, L.D. (2007) MAPK Phosphatases—Regulating the Immune Response. Nature Reviews Immunology, 7, 202-212.

[74]   Shankar, S.P., Wilson, M.S., DiVietro, J.A., Mentink-Kane, M.M., Xie, Z., Wynn, T.A. and Druey, K.M. (2012) RGS16 Attenuates Pulmonary Th2/Th17 Inflammatory Responses. Journal of Immunology, 188, 6347-6356.

[75]   Shi, G.X., Harrison, K., Han, S.B., Moratz, C. and Kehrl, J.H. (2004) Toll-Like Receptor Signaling Alters the Expression of Regulator of G Protein Signaling Proteins in Dendritic Cells: Implications for G Protein-Coupled Receptor Signaling. Journal of Immunology, 172, 5175-5184.

[76]   Wullaert, A., Verstrepen, L., Van Huffel, S., Adib-Conquy, M., Cornelis, S., Kreike, M., Haegman, M., El Bakkouri, K., Sanders, M., Verhelst, K., Carpentier, I., Cavaillon, J.M., Heyninck, K. and Beyaert, R. (2007) LIND/ABIN-3 Is a Novel Lipopolysaccharide-Inducible Inhibitor of NF-kappaB Activation. Journal of Biological Chemistry, 282, 81-90.

[77]   Echlin, D.R., Tae, H.J., Mitin, N. and Taparowsky, E.J. (2000) B-ATF Functions as a Negative Regulator of AP-1 Mediated Transcription and Blocks Cellular Transformation by Ras and Fos. Oncogene, 19, 1752-1763.

[78]   Dinarello, C.A. (2011) A Clinical Perspective of IL-1beta as the Gatekeeper of Inflammation. European Journal of Immunology, 41, 1203-1217.

[79]   Erickson, S.L., de Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V. and Moore, M.W. (1994) Decreased Sensitivity to Tumour-Necrosis Factor but Normal T-Cell Development in TNF Receptor-2-Deficient Mice. Nature, 372, 560-563.

[80]   Peschon, J.J., Torrance, D.S., Stocking, K.L., Glaccum, M.B., Otten, C., Willis, C.R., Charrier, K., Morrissey, P.J., Ware, C.B. and Mohler, K.M. (1998) TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation. Journal of Immunology, 160, 943-952.

[81]   Corfe, S.A. and Paige, C.J. (2012) The Many Roles of IL-7 in B Cell Development; Mediator of Survival, Proliferation and Differentiation. Seminars in Immunology, 24, 198-208.

[82]   Huang, H.Y. and Luther, S.A. (2012) Expression and Function of Interleukin-7 in Secondary and Tertiary Lymphoid Organs. Seminars in Immunology, 24, 175-189.

[83]   Etzerodt, A. and Moestrup, S.K. (2013) CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects. Antioxidants & Redox Signaling, 18, 2352-2363.

[84]   Fabriek, B.O., Dijkstra, C.D. and van den Berg, T.K. (2005) The Macrophage Scavenger Receptor CD163. Immunobiology, 210, 153-160.

[85]   Chanson, M., Derouette, J.P., Roth, I., Foglia, B., Scerri, I., Dudez, T. and Kwak, B.R. (2005) Gap Junctional Communication in Tissue Inflammation and Repair. Biochimica et Biophysica Acta, 1711, 197-207.

[86]   Churko, J.M. and Laird, D.W. (2013) Gap Junction Remodeling in Skin Repair Following Wounding and Disease. Physiology (Bethesda), 28, 190-198.

[87]   Averill, M.M., Kerkhoff, C. and Bornfeldt, K.E. (2012) S100A8 and S100A9 in Cardiovascular Biology and Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 223-229.

[88]   Perera, C., McNeil, H.P. and Geczy, C.L. (2010) S100 Calgranulins in Inflammatory Arthritis. Immunology & Cell Biology, 88, 41-49.